in-situ hybridization market ppt

1. In-Situ Hybridization Market  Report 2019-2028 www.emergenresearch.com . 2 Increasing prevalence of cancer and genetic disorders and increasing investments in R&D for cancer diagnosis are some key factors driving global in-situ hybridization market growth.

2. Our Model Market Analysis Financial Analysis Distribution Channel Analysis Brand Analysis Custom Market Intelligence Competitor Analysis Product Analysis Custom Research www.emergenresearch.com Demand Analysis Risk Analysis

3. Business Plan Parameters End Use Analysis Demand Availability Analytics Market Entry Strategy Restructuring & Revival New Product Strategy Product Planning / Strategy SWOT Analysis Marketing / Distribution Channel Feasibility www.emergenresearch.com Customer Identification Survey Competitive Landscape / M&A Feasibility www.emergenresearch.com

4. Industries We Cater to Food & Beverages Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health Food and Sports Nutrition, Frozen and Processed Food, Household, Retail Power & Energy Oil and Gas, Electricity, Energy Storage, Environmental, Renewable Energy Automotive Services Information and Tech Electric and Hybrid Vehicles, Off Highway and On Highway Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior Materials, Automotive electronics and Systems Data Security, Cloud Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce www.emergenresearch.com Pharma & Healthcare Materials and Chemicals Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings 5

5. Market Summary The global in-situ hybridization market size reached USD 905.3 Million in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer, genetic disorders, and infectious diseases is expected to drive revenue growth of the global in-situ hybridization market during the forecast period. According to the Center for Disease Control and Prevention, in 2019, cancer was the second leading cause of death in the US. Around 599,601 cancer deaths occurred in 2019, among which 283,725 were female, and 315,879 were male. Rising prevalence is resulting in need for developing more effective treatment techniques by pharma companies for early detection of infected cells and tissues. Increasing pharmaceutical research and development activities to diagnose cancer and other infectious diseases is expected to augment growth of the global in-situ hybridization market going ahead. In addition, growing number of diagnostic centers for cancer globally are expected to further boost revenue growth of the global in-situ hybridization market in the near future. However, high cost of in-situ hybridization-based treatment is a major factor expected to hamper global in-situ hybridization market growth to a certain extent during the forecast period. www.emergenresearch.com

6. Market Summary Further key findings from the report suggest The fluorescence in-situ hybridization segment is expected to lead in terms of revenue contribution to the global in-situ hybridization market during the forecast period due to rising application of fluorescence in-situ hybridization technology for defected chromosome identification, unusual genetic conditions, and drug tracking. Cancer diagnostic segment revenue is expected to expand at a significant CAGR during the forecast period. Increasing demand for FISH technology for early detection of cancer cells is driving revenue growth of this segment. Kits & reagents segment is expected to account for higher revenue share among the product type segments. This growth can be attributed to increasing need for various kits to perform pre-hybridization, post-hybridization, and hybridization treatments. Request Free Sample : https://www.emergenresearch.com/request-sample/584 www.emergenresearch.com

7. Market Summary Some Key Highlights From the Report North America is expected to account for largest revenue share due to increasing advancements in health infrastructure and rising investment in biomedical R&D activities in countries in the region. In addition, growing number of clinical laboratories and research institutions in the US is expected to boost growth of the market in the region. Key players in the market include Thermo Fisher Scientific, Biocare Medical, Agilent Technologies, Abbott Laboratories, Abnova Corporation, Hoffmann-La Roche Ltd., Merck KGAa, Danaher Corporation, Bio SB, and BioGenex Laboratories. In March 2021, Agilent Technologies announced plans to acquire Resolution Bioscience Inc. This acquisition will strengthen the position of Agilent Technologies for cancer diagnostics. Request Free Sample Copy@https://www.emergenresearch.com/request-sample/584 www.emergenresearch.com

8. Market Summary • Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, test type, technology, instrument, end-users, and region: • Technology Outlook (Revenue, USD Million; 2018–2028) • Fluorescence In-Situ Hybridization (FISH) • Chromogenic In-Situ Hybridization (CISH) • Application Outlook (Revenue, USD Million; 2018–2028) • Cancer Diagnostic • Infectious Disease • Immunology • Neuroscience • Cytology • Others • Read More@https://www.emergenresearch.com/industry-report/in-situ-hybridization-market

9. Market Summary Product Type Outlook (Revenue, USD Million; 2018–2028) Kits & Reagents Probes Instruments Software Others End-use Outlook (Revenue, USD Million; 2018–2028) Diagnostics Laboratories and Hospitals Pharmaceutical & Bio-technology Academic & Research Institute Contract Research Organizations (CRO) Read more: https://www.emergenresearch.com/industry-report/in-situ-hybridization-market

10. MARKETSEGMENTATION www.emergenresearch.com

11. Regional Share Dynamics www.emergenresearch.com

12. LATEST PUBLICATIONS Related reports: Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market Nucleic Acid Isolation and Purification Market:  https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market Non-Invasive Prenatal Testing Market:    https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market RNA Transcriptomics Market:   https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5 www.emergenresearch.com

13. About Us At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade. Our expertise umbrellas the technological environment of all major industries, and our services help you map your actions to ensure optimal yield. Our analysts utilize their market proficiency to offer actionable insights that help our clients implement profitable strategies and optimize their return on investment. Our services are wide-ranging, right from technological environment analysis to technological profiling that highlights the existing opportunities in the market you can capitalize on to stay ahead of your competitors. www.emergenresearch.com

14. Lets Talk; Contact Information Reach out to us and our Research Executives will ensure you get the report that meets all your requirements and address all your concerns. 14671 110 Avenue, Surrey, British Columbia, V3R2A9 www.emergenresearch.com www.emergenresearch.com sales@emergenresearch.com +1 (604) 757-9756